Choroid plexus carcinoma (CPC) is a malignant neoplasm arising from the choroid plexus. It is classified as a WHO grade III tumour and while there is considerable overlap in imaging characteristics it carries significantly poorer prognosis than choroid plexus papilloma (CPP).
On this page:
Choroid plexus carcinomas occurs predominantly in children, typically in the first 5 years of life. They are rare, far less common than choroid plexus papillomas (which account for 80% of primary choroid plexus tumours), representing only 1-4% of paediatric brain tumours 5,7.
As is the case with choroid plexus papillomas, presentation usually is as a result of hydrocephalus. Symptoms include increasing head circumference and headaches. Papilloedema may be visible on fundoscopy. In addition, choroid plexus carcinomas have a tendency to invade adjacent brain and thus may present with focal neurological dysfunction 7.
They originate from choroid plexus epithelium and typically arise de novo; some may via malignant transformation of a choroid plexus papilloma 4.
Macroscopically, they are lobulated masses with cystic and necrotic areas with loss of the papillary cytoarchitecture seen in both the normal choroid plexus and CPP 4.
Microcalcifications and haemorrhage may be present. Brain parenchymal invasion is a feature, and if present distinguishes choroid plexus carcinomas from choroid plexus papillomas.
The most common underlying genetic mechanism identified in their formation is dysfunction of the p53 tumour suppressor gene.
- Li-Fraumeni syndrome 5
- Simian Virus 40 (SV40) on the basis of this virus' DNA having been identified in up to 50% of cases 5
Choroid plexus carcinomas are markedly enhancing intraventricular tumours, usually arising in the trigone of a lateral ventricle and invading adjacent brain parenchyma.
Hydrocephalus may be present but is less likely than with choroid plexus papillomas. In CPC, hydrocephalus is generally a consequence of CSF pathway obstruction by the mass or a metastases whereas in CPP, there is at least a component of CSF overproduction.
On non-contrast CT choroid plexus carcinomas are heterogeneous and typically iso to hyperdense to grey matter. Calcification may be seen in 20-25% of cases.
Contrast enhancement is usually prominent but heterogeneous with areas of necrosis and cyst formation evident.
Reported signal characteristics include
- T1: iso- to hypointense
- T2: iso- to hypointense with hyperintense necrotic areas
- T2* GRE: blooming from calcifications/haemorrhage
- T1 C+ (Gd): can show marked, heterogeneous enhancement.
The tumours may have CSF seeding, therefore imaging of the entire neural axis is recommended prior to surgery.
Treatment and prognosis
Choroid plexus carcinomas are rapidly growing tumours with a 40% 5-year survival. TP53 mutation, brain invasion and CSF seeding are considered poor prognostic factors 3-5.
Surgical en-bloc resection is the mainstay of treatment and can result in cure, achieved in as many as 50% of cases, but this result has only been reported in some selected series 5. In general survival seems to be much worse than this, and hinges upon the ability to achieve gross complete macroscopic resection. In such cases a 5-year survival of up to 86% can be achieved. In cases where resection is incomplete, 5-year survival is much lower 26% 6. Both radiotherapy and chemotherapy are used 5.
General imaging differential considerations include:
choroid plexus papilloma
- lack of necrosis,
- lack of cerebral parenchymal invasion
- it is difficult to categorically distinguish CPP from CPC and as such biopsy is required.
- older demographic
- usually in the body of the lateral ventricle, typically abutting the septum pellucidum
- older demographic
- more homogeneous outline and contrast enhancement
choroid plexus metastasis
- rare in children
- 1. Koeller KK, Sandberg GD. From the archives of the AFIP. Cerebral intraventricular neoplasms: radiologic-pathologic correlation. Radiographics. 22 (6): 1473-505. doi:10.1148/rg.226025118 - Pubmed citation
- 2. Silver AJ, Ganti SR, Hilal SK. Computed tomography of tumors involving the atria of the lateral ventricles. Radiology. 1982;145 (1): 71-8. Radiology (abstract) - Pubmed citation
- 3. Osborn AG. Diagnostic imaging, Brain. Saunders. (2004) ISBN:0721629059. Read it at Google Books - Find it at Amazon
- 4. Tortori-Donati P. Pediatric neuroradiology. Springer. (2005) ISBN:3540410775. Read it at Google Books - Find it at Amazon
- 5. Custodio G, Taques GR, Figueiredo BC et-al. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PLoS ONE. 22;6 (3): e18015. doi:10.1371/journal.pone.0018015 - Free text at pubmed - Pubmed citation
- 6. Berger C, Thiesse P, Lellouch-Tubiana A et-al. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery. 1998;42 (3): 470-5. Pubmed citation
- 7. Grygotis LA, Chew FS. Choroid plexus carcinoma of the lateral ventricle. AJR Am J Roentgenol. 1997;169 (5): 1400. AJR Am J Roentgenol (citation) - Pubmed citation